Objectives

Long-Term Prognostic Value of Resting Heart Rate

Large Clinical Trials on Heart Rate Reduction

Ivabradine and If Channel

Discharge HR and Risk of 1-Year Mortality in Patients With HF

HR Distribution in Heart Failure

Systolic Heart Failure Treatment With

the If Inhibitor Ivabradine Trial (SHIFT)

Effect of Ivabradine on Outcomes

Summary of Heart Rate and Heart Failure

Abbreviations

References

References (cont)